
Finland · Medical devices startup
HVR Cardio Oy is a Finnish medical device company located in Espoo, specializing in cardiovascular solutions.
Funding reportedLast round: Series B
Follow HVR Cardio Oy and see its new rounds in your feed.Start following
HVR Cardio Oy is a Finnish medical device company located in Espoo, specializing in cardiovascular solutions.
The company focuses on developing innovative treatments for mitral valve repair, particularly for mitral regurgitation, using its proprietary HELIX technology and the CathHELIX system. The main product is the CathHELIXTM Annuloplasty System, designed to provide a minimally invasive option for mitral valve repair. This system aims to simplify the procedure and reduce trauma compared to traditional surgery. HVR Cardio also has a broader portfolio that includes annuloplasty rings, cardiovascular catheters, and instruments related to heart valve repair. HVR Cardio targets structural heart physicians, cardiologists, and cardiac surgery professionals, offering solutions for patients with mitral regurgitation. The company emphasizes its commitment to advancing treatment options in the field of structural heart care.
Funding, as reported
What they build
Known for
health caremitral regurgitation treatmenttranscatheter annuloplastymedical equipment manufacturinginnovative mitral valve devicestructural heart diseaseearly treatment optionhospital & health caresurgical mitral repairnative leaflet functionhealthtranscatheter mitral repairregulatory approvalcardiovascular interventionmedical devicesmitral regurgitation therapy
Built with from their website
WordPress.orgGoogle CloudViewport MetaTrustArcVarnishwebpackBarracuda MSPGoogle Cloud HostingPriority HintsReact
Google Font APIMicrosoft ExchangeSirvoyWix eCommerceMicrosoft 365 Apps & ServicesWebsiteBuilderMobile FriendlyLodash
Add your raise, your deck and your story, and put HVR Cardio Oy in front of investors. Or tell us what we have wrong.